Results 1 to 10 of about 2,196,135 (231)

Drug-Coated Balloon PCI in Different Plaque Morphologies: A Narrative Review

open access: yesBiomedicines
The evolution of percutaneous coronary intervention (PCI) has led to significant advances in drug-coated balloon (DCB) technology, offering a stent-free alternative for treating coronary artery disease.
Flavius-Alexandru Gherasie   +2 more
doaj   +3 more sources

Coronary Artery Aneurysm Post Drug-Coated Balloon Angioplasty

open access: yesJACC: Case Reports
Drug-coated balloons have emerged as effective therapy for treating in-stent restenosis and de novo lesions. The animal studies have shown the mechanism of action of paclitaxel-coated balloon in coronary arteries which leads to medial necrosis that may ...
Aninka Saboe, MD   +3 more
doaj   +2 more sources

Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium [PDF]

open access: yesEuropean Heart Journal
The Drug Coated Balloon Academic Research Consortium project originated from the lack of standardization and comparability between studies using drug-coated balloons in the treatment of obstructive coronary artery disease.
S. Fezzi   +31 more
semanticscholar   +3 more sources

Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date

open access: yesVascular Health and Risk Management, 2016
Mohamed Barkat,1 Francesco Torella,1 George A Antoniou2 1Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, 2Department of Vascular and Endovascular Surgery, The Royal Oldham Hospital, Pennine Acute Hospitals NHS
Barkat M, Torella F, Antoniou GA
doaj   +1 more source

Predictors of optimal angiographic lesion outcomes in drug-coated balloon treatment for de novo coronary artery disease

open access: yesScientific Reports
Drug-coated balloon (DCB) treatment is an emerging strategy for de novo coronary artery disease (CAD), but procedural optimization remains uncertain. This study analyzed 317 patients who underwent DCB-based intervention for de novo CAD and angiographic ...
Dong Oh Kang   +10 more
doaj   +2 more sources

Drug-Coated Balloon Treatment of Very Late Stent Thrombosis Due to Complicated Neoatherosclerosis

open access: yesArquivos Brasileiros de Cardiologia, 2016
We describe the treatment of a patient presenting with very-late stent thrombosis with the use of a drug-coated balloon. In this patient, optical coherence tomography disclosed that ruptured and complicated neoatherosclerosis was the underlying substrate
Fernando Alfonso   +4 more
doaj   +2 more sources

New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease

open access: yesMedical Devices: Evidence and Research, 2016
Jesse Naghi, Ethan A Yalvac, Ali Pourdjabbar, Lawrence Ang, John Bahadorani, Ryan R Reeves, Ehtisham Mahmud, Mitul Patel Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, CA, USA Abstract ...
Naghi J   +7 more
doaj   +1 more source

Analysis of drug gene detection after intracranial drug-coated balloon operation

open access: yesGuoji laonian yixue zazhi
[Objective] To observe the difference between antiplatelet therapy after drug-coated balloon angioplasty guided by drug gene detection and conventional antiplatelet therapy, and to evaluate the benefit of drug gene guided medication. [Methods] 80 elderly
Wu Mingxin   +3 more
doaj   +2 more sources

How much of the intraaortic balloon volume is displaced toward the coronary circulation? [PDF]

open access: yes, 2010
This is a post-print version of the published article. Copyright @ 2010 The American Association for Thoracic Surgery.This article has been made available through the Brunel Open Access Publishing Fund.Objective: During intraaortic balloon inflation ...
Pantalos, GM   +7 more
core   +7 more sources

Home - About - Disclaimer - Privacy